Paperonium

← Back to the plain-language case

Abstract gives an onset age and female share that contradict the paper's own Table 1

Neurology (2025) · doi:10.1212/WNL.0000000000214316 · PMC12615010

Summary

The abstract describes the 140 autopsy-confirmed patients with multiple system atrophy (MSA) as having a "mean age at onset 62.3 ± 8.9 years" and as "44% female". Table 1 gives the same 140 patients a mean age at onset of 57.4 ± 8.5 years and a male:female split of 59:81, which is 57.9% female. The table checks out from several directions. Its subgroup counts sum to 59 men and 81 women in both of its groupings, the size-weighted mean of its subgroup onset ages is 57.40 years, and every one of its 11 subgroup mean onset ages is 59.7 years or less, so the overall mean cannot be 62.3. The paper's inferential results are not affected. However, the abstract, which is the part most often read and indexed on its own, makes the cohort look 4.9 years older at onset than it is and shows men, not women, as the majority.

What the paper reports

All quotations were checked verbatim against the PMC-archived text with src/show.py.

Abstract, Results:

Among 140 patients (mean age at onset 62.3 ± 8.9 years; 44% female), 81 (58%) initially presented without dysautonomia (57 with parkinsonism only, 17 with cerebellar syndrome only, 7 with both).

Table 1 ("Demographic Data"), All patients column:

M:F, n [%] | 59:81 [42:58]

Age at onset, y, mean ± SEM [range; median] | 57.4 ± 8.5 [35–80; 57.5]

Age of death, y, mean ± SEM [range; median] | 64.8 ± 7.7 [40–90; 64.5]

Disease duration, y, mean ± SEM [range; median] | 7.4 ± 3 [2–20; 7]

Table 1, M:F row by phenotype at onset (A, P, C, P+A, C+A, P+C, P+C+A):

16:11a [59:41] | 20:37a [35:65] | 11:6a [65:35] | 5:14 [26:74] | 2:2 [50:50] | 3:4 [37:63] | 2:7 [22:78]

Results, "Characteristics of Patients and of Clinical Phenotypes at Disease Onset":

We included a total of 140 autopsy-confirmed patients with MSA who had sufficient clinical data regarding disease progression in the analysis. The demographic characteristics and basic parameters of the study population are summarized in Table 1.

A significant association was found between sex and phenotype A, P, and C at onset, χ2(2, N = 101) = 7.015, p = 0.030, indicating a higher prevalence of P in women (n = 20 m vs n = 37 f) and of C (n = 11 m vs n = 6 f) and A (16 m vs 11 f) in men.

Methods, "Patients and Clinical Data":

The cohort has been described in previously published work, comprising 144 patients with a pathologic diagnosis of MSA.

Methods, "Statistical Analysis":

Demographic data were presented as means ± SD, ranges, and medians.

What the paper's own numbers show

Method. I transcribed the All patients column of Table 1 and every subgroup column: 7 groups by phenotype at onset and 4 groups by phenotype at final visit, each a partition of the 140 patients. I summed the subgroup sex counts. I pooled the subgroup onset means weighted by subgroup size, and pooled the spreads as SDs (within-group plus between-group variance). As a further check, I compared onset age with mean age at death minus mean disease duration. I also recomputed the Results-text chi-square from its counts, to confirm that the table's sex counts are the ones the analysis used. Every number below is printed by recompute.py.txt.

Quantity Location Reported Recomputed from the paper's own numbers
Mean age at onset, all 140 Abstract, Results 62.3 ± 8.9 y 57.40 ± 8.49 y (n-weighted pool of the 7 onset groups)
Mean age at onset, all 140 Table 1, All patients 57.4 ± 8.5 57.40 (onset groups); 57.51 (final-visit groups)
Highest subgroup mean onset age Table 1, 11 subgroup columns 55.9 to 59.7 maximum 59.7 (final P+C, n = 12); a pooled mean cannot exceed it
Age at death − disease duration Table 1, All patients 64.8 and 7.4 64.8 − 7.4 = 57.4; n-weighted onset groups: 64.80 − 7.44 = 57.37
Female share Abstract, Results 44% 81/140 = 57.9%
Sex counts Table 1, M:F 59:81 [42:58] onset groups sum to M 59, F 81; final-visit groups sum to M 59, F 81; M + F = n in every column
44% of 140 derived — 61.6 women (61/140 = 43.6%, 62/140 = 44.3%); matches no count in the paper
Male share Table 1 42% 59/140 = 42.1% (so 44% is not the male share either)
Sex × onset phenotype (A, P, C) Results text χ²(2, N = 101) = 7.015, p = 0.030 7.015, p = 0.030 from counts 16/11, 20/37, 11/6, which equal the Table 1 counts
Differences, abstract vs table — — onset age +4.9 y; female share −13.9 percentage points

Table 1 is internally consistent and agrees with the Results text. Its subgroup counts, subgroup means and overall column fit together to the precision of the printed figures. The pooled SD of 8.49 even reproduces the overall spread of 8.5. The abstract's two demographic figures match nothing in the paper. The 62.3-year mean is 2.6 years above the highest of the 11 subgroup means. Taken against the table's mean age at death of 64.8, it would leave about 2.5 years from onset to death, while the table's mean disease duration is 7.4 years. The 44% female share would mean 61.6 women, which is not a whole number of patients. It is not the male share (42.1%) either.

Figure

The abstract and Table 1 give different onset ages and female shares for the same 140 patients

Figure 1. The two conflicting passages side by side. Left (orange): the abstract's description of the cohort, quoted verbatim, which gives an onset age of 62.3 years and 44% female. Right (blue): the Table 1 All patients cells, quoted with the row label shortened, and the values recomputed from the table's own subgroup columns, which give an n-weighted onset age of 57.40 years and 81/140 = 57.9% female. Both passages describe the same 140 patients. The abstract's onset age is 4.9 years higher than the table's, and its female share is 13.9 percentage points lower, which turns a female-majority cohort into an apparent male-majority one. The 44% also does not equal the table's male share (42.1%).

Every Table 1 subgroup mean onset age lies below the abstract's overall mean, and the sex counts sum to 81 women

Figure 2. Left: mean age at onset in each Table 1 subgroup (open circles, labelled with subgroup size), shown for the 7 groups by phenotype at onset and the 4 groups by phenotype at final visit. Below them are the n-weighted pooled mean recomputed from the onset groups (blue circle, 57.40) and the abstract's overall mean (orange diamond, 62.3). The dotted line marks the highest subgroup mean (59.7). A weighted mean of the subgroup means cannot exceed it, so 62.3 cannot be the mean of these patients. Right: number of patients by sex. The open bar is the 59 men and the blue bar is the 81 women, both summed from the Table 1 subgroups. The orange bar is the number of women implied by the abstract's 44% of 140, which is 61.6. The x-axis starts at 0 on the right panel. On the left it spans 50 to 65 years, so the gap between 57.4 and 62.3 is shown at true scale against the spread of the subgroup means.

Why it matters

Explanations considered

Status

Suggested correction

In the abstract Results, replace

Among 140 patients (mean age at onset 62.3 ± 8.9 years; 44% female)

with

Among 140 patients (mean age at onset 57.4 ± 8.5 years; 58% female)

so that it matches Table 1 (M:F 59:81; age at onset 57.4 ± 8.5 years). If 62.3 ± 8.9 years and 44% female describe some other group, the abstract should name that group. The authors may also wish to relabel the Table 1 spreads from "SEM" to "SD", in line with the Methods and with the values. They may also wish to reconcile "Fifty patients (36%)" for the P+A group in the Results text with the 49 [35] in Table 1.